Crohn's Disease
828
74
96
473
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
204 trials with published results (25%)
Research Maturity
473 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
13.6%
113 terminated out of 828 trials
80.7%
-5.8% vs benchmark
26%
215 trials in Phase 3/4
43%
204 of 473 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 473 completed trials
Clinical Trials (828)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
A Phase 2 Study of SL-325 in Crohn's Disease Patients
A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
ENhanced Recovery in CHildren Undergoing Surgery
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ustekinumab Real World Evidence Study
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD
A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease